Inventor · disambiguated record
Dongxu Sun
Also filed as: SUN DONGXU
20 granted patents·16 pending applications·203 citations·filing 1996–2025
95Inventor score
Files withTRUEBINDING INC18ICONIX PHARM INC7MICROCIDE PHARMACEUTICALS INC4ESSENTIAL THERAPEUTICS INC3MPEX PHARMACEUTICALS INC2
Top patents by PatentIndex Score
36 records- 0191US11427638B2Anti-Gal3 antibodies and uses thereofTRUEBINDING INC·Filed 2021·Granted Aug 30, 2022·5 cites·5 claims
- 0290US7053216B2Modulators of Rho C activityICONIX PHARM INC·Filed 2002·Granted May 30, 2006·29 cites·4 claims
- 0389US7893020B2Bacterial efflux pump inhibitors and methods of treating bacterial infectionsMPEX PHARMACEUTICALS INC·Filed 2005·Granted Feb 22, 2011·13 cites·25 claims
- 0487US12497458B2Anti-GAL3 antibodies and uses thereofTRUEBINDING INC·Filed 2022·Granted Dec 16, 2025·1 cites·5 claims
- 0587US12227567B2Treating cancer by blocking the interaction of TIM-3 and its ligandTRUEBINDING INC·Filed 2018·Granted Feb 18, 2025·2 cites·15 claims
- 0683US6642263B2Modulators of Rho C activityICONIX PHARM INC·Filed 2002·Granted Nov 4, 2003·13 cites·16 claims
- 0782US7879795B2Enhancement of tigecycline potency using efflux pump inhibitorsMPEX PHARMACEUTICALS INC·Filed 2007·Granted Feb 1, 2011·2 cites·24 claims
- 0882US6638718B1Methods of screening for compounds active on staphylococcus aureus target genesESSENTIAL THERAPEUTICS INC·Filed 2000·Granted Oct 28, 2003·8 cites·7 claims
- 0982US6630303B1Methods of screening for compounds active on Staphylococcus aureus target genesESSENTIAL THERAPEUTICS INC·Filed 2000·Granted Oct 7, 2003·8 cites·7 claims
- 1080US2024182564A1Treating cancer by blocking the interaction of tim-3 and its ligandTRUEBINDING INC·Filed 2023·Application pending·0 cites
- 1179US6037123AMethods of screening for compounds active on Staphylococcus aureus target genesMICROCIDE PHARMACEUTICALS INC·Filed 1996·Granted Mar 14, 2000·45 cites·60 claims
- 1278US12281166B2Methods of treating inflammatory diseases by blocking Galectin-3TRUEBINDING INC·Filed 2021·Granted Apr 22, 2025·1 cites·9 claims
- 1374US6800634B2Modulators of Rho C activityICONIX PHARM INC·Filed 2002·Granted Oct 5, 2004·7 cites·14 claims
- 1473US6228588B1Methods of screening for compounds active on Staphylococcus aureus target genesMICROCIDE PHARMACEUTICALS INC·Filed 1999·Granted May 8, 2001·30 cites·66 claims
- 1573US2025171539A1Treating cancer by blocking the interaction of tim-3 and its ligandTRUEBINDING INC·Filed 2025·Application pending·0 cites
- 1672US7049468B2Modulators of Rho C activityICONIX PHARM INC·Filed 2002·Granted May 23, 2006·6 cites·5 claims
- 1768US6908932B2Modulators of phosphoinositide 3-kinaseICONIX PHARM INC·Filed 2002·Granted Jun 21, 2005·5 cites·20 claims
- 1865US6187541B1Methods of screening for compounds active on staphylococcus aureus target genesMICROCIDE PHARMACEUTICALS INC·Filed 1999·Granted Feb 13, 2001·18 cites·66 claims
- 1964US6894055B2Thieno-2′,3′ -5,6pyrimido[3,4-A]-1,2,4-triazole derivatives as modulators of phoshoinositide 3-kinaseICONIX PHARM INC·Filed 2002·Granted May 17, 2005·4 cites·11 claims
- 2061US2024158512A1Anti-gal3 antibody formulations and methods of use thereofTRUEBINDING INC·Filed 2023·Application pending·0 cites
- 2160US2023036181A1Anti-gal3 antibodies and methods of useTRUEBINDING INC·Filed 2022·Application pending·0 cites
- 2257US2025243282A1Methods of treating inflammatory diseases by blocking galectin-3TRUEBINDING INC·Filed 2025·Application pending·0 cites
- 2357US2024352131A1Methods of treating eye diseaseTRUEBINDING INC·Filed 2024·Application pending·0 cites
- 2451US2007059709A1Staphylococcus aureus antibacterial target genesBENTON BRET·Filed 2003·Application pending·0 cites
- 2550US2025145722A1Anti-gal3 antibodies and methods of useTRUEBINDING INC·Filed 2025·Application pending·0 cites
- 2650US2022411514A1Anti-gal3 antibodies and methods of use for insulin resistanceTRUEBINDING INC·Filed 2022·Application pending·0 cites
- 2749US2025026838A1Methods of preventing protein aggregationTRUEBINDING INC·Filed 2022·Application pending·0 cites
- 2847US5962249ASized-based marker identification technologyMICROCIDE PHARMACEUTICALS INC·Filed 1996·Granted Oct 5, 1999·6 cites·34 claims
- 2947US2023279120A1Methods of treating or inhibiting cardiovascular diseasesTRUEBINDING INC·Filed 2022·Application pending·0 cites
- 3046US2023094463A1Antibodies that disrupt the interaction of gal3 and insulin receptor or integrins and methods of use thereofTRUEBINDING INC·Filed 2020·Application pending·0 cites
- 3146US2022281973A1Antibodies and blocking the interaction of vista and its binding partnerTRUEBINDING INC·Filed 2020·Application pending·0 cites
- 3245US2009023144A1Method and its kit for quantitatively detecting specific analyte with single capturing agentXUZHOU LINGXIN BIOSCIENCES INC·Filed 2006·Application pending·0 cites
- 3343US2021363255A1Methods and compositions for blocking interaction between non-glycosylated pd-1 polypeptidesTRUEBINDING INC·Filed 2019·Application pending·0 cites
- 3442US2021085785A1Treating cancer by blocking the interaction of vista and its binding partnerTRUEBINDING INC·Filed 2019·Application pending·0 cites
- 3537US6537996B2Modulators of p38 MAP kinaseICONIX PHARM INC·Filed 2001·Granted Mar 25, 2003·0 cites·14 claims
- 3630US6514746B1Staphylococcus aureus histidine protein kinase essential genesESSENTIAL THERAPEUTICS INC·Filed 1998·Granted Feb 4, 2003·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Dongxu Sun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →